Product Information
FAMOTIDINE 40 MG/5 ML SUSP is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $0.1305 per ML under NDC 68382044405. Its NADAC has been published 538 times since Nov 28, 2013.
FDA first approved this application on May 27, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
40 mg/5mL
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382044405
Classification
Generic
Dosage Form
POWDER, FOR SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FAMOTIDINEApproval Type
Generic (ANDA)
FDA Application
ANDA091020FDA Approved
5/27/2010
TE Code
AB
On Market Since
4/22/2021
Pharmacological Classes
Price Statistics
The NADAC for FAMOTIDINE 40 MG/5 ML SUSP has been published 538 times since Nov 28, 2013, and over the history we have for it it has declined 86.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1305 per ML |
|---|---|
| All-time high | $1.1937 (Oct 13, 2021) |
| All-time low | $0.1305 (Sep 23, 2026) |
| 52-week high | $0.2148 |
| 52-week low | $0.1305 |
| Median price | $0.8093 |
| Average price | $0.7179 |
| Largest weekly change | +42.6% (Aug 25, 2021) |
| Weeks tracked | 538 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the famotidine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zydus Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
famotidine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-2 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FAMOTIDINE 40 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for FAMOTIDINE 40 MG/5 ML SUSP, manufactured by Zydus Pharmaceuticals (USA) Inc., is $0.1305 per ML (NDC 68382044405), effective Sep 30, 2026.
How has the price of FAMOTIDINE 40 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has declined 86.8%. It has been tracked across 538 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FAMOTIDINE 40 MG/5 ML SUSP?
Since Nov 28, 2013, the NADAC for FAMOTIDINE 40 MG/5 ML SUSP has ranged from a low of $0.1305 (Sep 23, 2026) to a high of $1.1937 (Oct 13, 2021), with a median of $0.8093 per ML.
Are there cheaper alternatives to FAMOTIDINE 40 MG/5 ML SUSP?
No other NADAC-published product currently shares the active ingredient and strength of FAMOTIDINE 40 MG/5 ML SUSP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FAMOTIDINE 40 MG/5 ML SUSP?
FAMOTIDINE 40 MG/5 ML SUSP (NDC 68382044405) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.